

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | glomerular basement membrane development (GO:0032836) | 7.61925212 |
| 2 | triglyceride catabolic process (GO:0019433) | 6.99977546 |
| 3 | gonadal mesoderm development (GO:0007506) | 6.45497496 |
| 4 | glomerular visceral epithelial cell development (GO:0072015) | 6.42421707 |
| 5 | neutral lipid catabolic process (GO:0046461) | 6.39115483 |
| 6 | acylglycerol catabolic process (GO:0046464) | 6.39115483 |
| 7 | positive regulation of male gonad development (GO:2000020) | 5.81009420 |
| 8 | glomerular epithelial cell development (GO:0072310) | 5.72368946 |
| 9 | surfactant homeostasis (GO:0043129) | 5.62504105 |
| 10 | sex determination (GO:0007530) | 5.12179109 |
| 11 | regulation of male gonad development (GO:2000018) | 5.10844002 |
| 12 | NADH metabolic process (GO:0006734) | 4.88740482 |
| 13 | vascular endothelial growth factor signaling pathway (GO:0038084) | 4.69794385 |
| 14 | glycerolipid catabolic process (GO:0046503) | 4.51208303 |
| 15 | low-density lipoprotein particle clearance (GO:0034383) | 4.50305537 |
| 16 | C21-steroid hormone biosynthetic process (GO:0006700) | 4.39934971 |
| 17 | negative regulation of granulocyte differentiation (GO:0030853) | 4.36463374 |
| 18 | fatty acid homeostasis (GO:0055089) | 4.23722406 |
| 19 | transcytosis (GO:0045056) | 4.22011451 |
| 20 | chemical homeostasis within a tissue (GO:0048875) | 4.19015414 |
| 21 | basement membrane organization (GO:0071711) | 4.13987901 |
| 22 | diacylglycerol metabolic process (GO:0046339) | 4.11191339 |
| 23 | cellular response to epinephrine stimulus (GO:0071872) | 4.10039637 |
| 24 | androgen biosynthetic process (GO:0006702) | 4.01081445 |
| 25 | polyol transport (GO:0015791) | 4.00248098 |
| 26 | barbed-end actin filament capping (GO:0051016) | 3.89134988 |
| 27 | apoptotic cell clearance (GO:0043277) | 3.87848893 |
| 28 | lymphangiogenesis (GO:0001946) | 3.86670657 |
| 29 | cGMP-mediated signaling (GO:0019934) | 3.85774193 |
| 30 | glomerulus development (GO:0032835) | 3.83397594 |
| 31 | lipid storage (GO:0019915) | 3.79629484 |
| 32 | alpha-linolenic acid metabolic process (GO:0036109) | 3.78780701 |
| 33 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.71019194 |
| 34 | adhesion of symbiont to host (GO:0044406) | 3.70345284 |
| 35 | renal filtration (GO:0097205) | 3.66560664 |
| 36 | cellular response to growth hormone stimulus (GO:0071378) | 3.62436991 |
| 37 | glucocorticoid biosynthetic process (GO:0006704) | 3.62392184 |
| 38 | regulation of cholesterol storage (GO:0010885) | 3.60009703 |
| 39 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.58048090 |
| 40 | positive regulation of glomerulus development (GO:0090193) | 3.53374437 |
| 41 | cellular response to interferon-alpha (GO:0035457) | 3.51708334 |
| 42 | positive regulation of cholesterol efflux (GO:0010875) | 3.49353760 |
| 43 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 3.48474754 |
| 44 | blood vessel endothelial cell migration (GO:0043534) | 3.47783683 |
| 45 | negative regulation of gluconeogenesis (GO:0045721) | 3.47304793 |
| 46 | lymph vessel development (GO:0001945) | 3.43183266 |
| 47 | cell migration involved in sprouting angiogenesis (GO:0002042) | 3.41820423 |
| 48 | positive regulation of p38MAPK cascade (GO:1900745) | 3.41700179 |
| 49 | response to epinephrine (GO:0071871) | 3.41575361 |
| 50 | urea cycle (GO:0000050) | 3.40323712 |
| 51 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.38787579 |
| 52 | fatty acid transmembrane transport (GO:1902001) | 3.38510883 |
| 53 | tricarboxylic acid metabolic process (GO:0072350) | 3.37762203 |
| 54 | positive regulation of vasculogenesis (GO:2001214) | 3.37037987 |
| 55 | white fat cell differentiation (GO:0050872) | 3.35440804 |
| 56 | endothelial cell chemotaxis (GO:0035767) | 3.34502219 |
| 57 | regulation of p38MAPK cascade (GO:1900744) | 3.34073275 |
| 58 | glomerular filtration (GO:0003094) | 3.33522236 |
| 59 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.33218527 |
| 60 | adhesion of symbiont to host cell (GO:0044650) | 3.32409822 |
| 61 | virion attachment to host cell (GO:0019062) | 3.32409822 |
| 62 | renal system process involved in regulation of blood volume (GO:0001977) | 3.30848662 |
| 63 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.30651753 |
| 64 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.28312666 |
| 65 | blood vessel maturation (GO:0001955) | 3.27071539 |
| 66 | negative regulation of complement activation (GO:0045916) | 3.23819967 |
| 67 | angiogenesis involved in wound healing (GO:0060055) | 3.23733225 |
| 68 | endothelial tube morphogenesis (GO:0061154) | 3.23265228 |
| 69 | morphogenesis of an endothelium (GO:0003159) | 3.23265228 |
| 70 | negative regulation of metanephros development (GO:0072217) | 3.21443192 |
| 71 | negative regulation of macrophage differentiation (GO:0045650) | 3.20879366 |
| 72 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.18278144 |
| 73 | anatomical structure regression (GO:0060033) | 3.17822174 |
| 74 | venous blood vessel morphogenesis (GO:0048845) | 3.17425736 |
| 75 | oxaloacetate metabolic process (GO:0006107) | 3.17251501 |
| 76 | positive regulation of protein kinase C signaling (GO:0090037) | 3.16789883 |
| 77 | cellular response to cadmium ion (GO:0071276) | 3.16150552 |
| 78 | carnitine shuttle (GO:0006853) | 3.16109281 |
| 79 | endocrine hormone secretion (GO:0060986) | 3.15854639 |
| 80 | response to dietary excess (GO:0002021) | 3.13860510 |
| 81 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.13087034 |
| 82 | triglyceride metabolic process (GO:0006641) | 3.11714570 |
| 83 | plasma lipoprotein particle clearance (GO:0034381) | 3.11226487 |
| 84 | keratan sulfate catabolic process (GO:0042340) | 3.11021435 |
| 85 | Leydig cell differentiation (GO:0033327) | 3.10717691 |
| 86 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.09974026 |
| 87 | regulation of gonadotropin secretion (GO:0032276) | 3.09932444 |
| 88 | macroautophagy (GO:0016236) | 3.09097691 |
| 89 | regulation of glycogen (starch) synthase activity (GO:2000465) | 3.08896786 |
| 90 | urea metabolic process (GO:0019627) | 3.08132190 |
| 91 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.08075420 |
| 92 | lipid particle organization (GO:0034389) | 3.06387864 |
| 93 | regulation of endothelial cell differentiation (GO:0045601) | 3.05751936 |
| 94 | endothelial cell morphogenesis (GO:0001886) | 3.05384684 |
| 95 | C21-steroid hormone metabolic process (GO:0008207) | 3.05070947 |
| 96 | negative regulation of protein activation cascade (GO:2000258) | 3.03752488 |
| 97 | intracellular lipid transport (GO:0032365) | 3.01673890 |
| 98 | positive regulation of metanephros development (GO:0072216) | 3.00759665 |
| 99 | embryonic foregut morphogenesis (GO:0048617) | 3.00162025 |
| 100 | regulation of female gonad development (GO:2000194) | 2.98723425 |
| 101 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.97968551 |
| 102 | positive regulation of vascular permeability (GO:0043117) | 2.97521396 |
| 103 | cAMP biosynthetic process (GO:0006171) | 2.97102740 |
| 104 | protein localization to cell surface (GO:0034394) | 2.97073506 |
| 105 | oocyte development (GO:0048599) | 2.97018867 |
| 106 | regulation of meiosis I (GO:0060631) | 2.96947171 |
| 107 | coronary vasculature morphogenesis (GO:0060977) | 2.96858134 |
| 108 | acylglycerol metabolic process (GO:0006639) | 2.96690650 |
| 109 | extracellular fibril organization (GO:0043206) | 2.95843286 |
| 110 | sex differentiation (GO:0007548) | 2.94516610 |
| 111 | glucocorticoid metabolic process (GO:0008211) | 2.94036485 |
| 112 | response to follicle-stimulating hormone (GO:0032354) | 2.91957420 |
| 113 | regulation of receptor binding (GO:1900120) | 2.91613914 |
| 114 | positive regulation of glucose import (GO:0046326) | 2.91484924 |
| 115 | nitrogen cycle metabolic process (GO:0071941) | 2.90805638 |
| 116 | neutral lipid metabolic process (GO:0006638) | 2.90564242 |
| 117 | positive regulation of cholesterol transport (GO:0032376) | 2.90301790 |
| 118 | positive regulation of sterol transport (GO:0032373) | 2.90301790 |
| 119 | brown fat cell differentiation (GO:0050873) | 2.88776021 |
| 120 | triglyceride biosynthetic process (GO:0019432) | 2.88391359 |
| 121 | negative regulation of vascular permeability (GO:0043116) | 2.87802559 |
| 122 | lung vasculature development (GO:0060426) | 2.87614031 |
| 123 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.87457747 |
| 124 | valine metabolic process (GO:0006573) | 2.87381974 |
| 125 | protein heterotrimerization (GO:0070208) | 2.86905106 |
| 126 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 2.85930258 |
| 127 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.85818392 |
| 128 | patterning of blood vessels (GO:0001569) | 2.84595458 |
| 129 | endothelium development (GO:0003158) | 2.82133061 |
| 130 | male sex determination (GO:0030238) | 2.81324205 |
| 131 | ethanol oxidation (GO:0006069) | 2.81065332 |
| 132 | negative regulation of DNA biosynthetic process (GO:2000279) | 2.80115099 |
| 133 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.78653263 |
| 134 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.78098819 |
| 135 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.77951823 |
| 136 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.77951823 |
| 137 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.77509349 |
| 138 | neutral lipid biosynthetic process (GO:0046460) | 2.75909233 |
| 139 | acylglycerol biosynthetic process (GO:0046463) | 2.75909233 |
| 140 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 2.75833584 |
| 141 | ovulation from ovarian follicle (GO:0001542) | 2.73552947 |
| 142 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.72510013 |
| 143 | establishment of endothelial barrier (GO:0061028) | 2.72221360 |
| 144 | estrogen biosynthetic process (GO:0006703) | 2.70913729 |
| 145 | regulation of glomerular filtration (GO:0003093) | 2.70820766 |
| 146 | regulation of vasculogenesis (GO:2001212) | 2.70722994 |
| 147 | ethanol metabolic process (GO:0006067) | 2.68368838 |
| 148 | progesterone metabolic process (GO:0042448) | 2.68006540 |
| 149 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.67819816 |
| 150 | epithelial cell-cell adhesion (GO:0090136) | 2.67642266 |
| 151 | stress fiber assembly (GO:0043149) | 2.66993068 |
| 152 | regulation of sequestering of triglyceride (GO:0010889) | 2.66788472 |
| 153 | fibroblast migration (GO:0010761) | 2.66019342 |
| 154 | synaptonemal complex assembly (GO:0007130) | 2.65897013 |
| 155 | regulation of cardioblast differentiation (GO:0051890) | 2.65074552 |
| 156 | reverse cholesterol transport (GO:0043691) | 2.62893886 |
| 157 | fibril organization (GO:0097435) | 2.62673605 |
| 158 | phagocytosis, recognition (GO:0006910) | 2.60856893 |
| 159 | lysine metabolic process (GO:0006553) | 2.59866996 |
| 160 | lysine catabolic process (GO:0006554) | 2.59866996 |
| 161 | biotin metabolic process (GO:0006768) | 2.58497132 |
| 162 | carnitine transmembrane transport (GO:1902603) | 2.56417012 |
| 163 | fatty acid beta-oxidation (GO:0006635) | 2.54272853 |
| 164 | regulation of endothelial cell chemotaxis (GO:2001026) | 2.54212439 |
| 165 | establishment of apical/basal cell polarity (GO:0035089) | 2.52116022 |
| 166 | positive regulation of lipid storage (GO:0010884) | 2.52082812 |
| 167 | plasma membrane fusion (GO:0045026) | 2.51450950 |
| 168 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.51434153 |
| 169 | protein localization to endosome (GO:0036010) | 2.50673072 |
| 170 | endothelial cell migration (GO:0043542) | 2.50159194 |
| 171 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.49084996 |
| 172 | carnitine transport (GO:0015879) | 2.47458063 |
| 173 | amino-acid betaine transport (GO:0015838) | 2.47458063 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.82172197 |
| 2 | CLOCK_20551151_ChIP-Seq_293T_Human | 4.20095991 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.06523903 |
| 4 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.33929998 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.11489406 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.07078377 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.96258830 |
| 8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.83794392 |
| 9 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.82674692 |
| 10 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.52841342 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.50024880 |
| 12 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.49796899 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.43080502 |
| 14 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.41349680 |
| 15 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.41349680 |
| 16 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.41349680 |
| 17 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.35664276 |
| 18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.35590375 |
| 19 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.32296148 |
| 20 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.28551363 |
| 21 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.97894784 |
| 22 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.97265953 |
| 23 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.93807636 |
| 24 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.88748203 |
| 25 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.82338978 |
| 26 | GATA1_22025678_ChIP-Seq_K562_Human | 1.80049075 |
| 27 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.77949113 |
| 28 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.77949113 |
| 29 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.74392089 |
| 30 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.69428589 |
| 31 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.68489719 |
| 32 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.63053649 |
| 33 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.60946248 |
| 34 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.57144142 |
| 35 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.55427786 |
| 36 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.55399496 |
| 37 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.51708929 |
| 38 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.50926039 |
| 39 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.49710961 |
| 40 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.48708961 |
| 41 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.46473840 |
| 42 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.44800747 |
| 43 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.44512776 |
| 44 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.41351613 |
| 45 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.40065520 |
| 46 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.39011107 |
| 47 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.37302344 |
| 48 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.34473725 |
| 49 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.33950576 |
| 50 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.33368113 |
| 51 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.32863793 |
| 52 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.32450477 |
| 53 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.30660916 |
| 54 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.30278520 |
| 55 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.30241825 |
| 56 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.27620905 |
| 57 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.25895148 |
| 58 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.24412771 |
| 59 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23779460 |
| 60 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.23212441 |
| 61 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.22399468 |
| 62 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.21942089 |
| 63 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.21455586 |
| 64 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.20338976 |
| 65 | GATA1_19941826_ChIP-Seq_K562_Human | 1.19233123 |
| 66 | ATF3_27146783_Chip-Seq_COLON_Human | 1.17481382 |
| 67 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.16646171 |
| 68 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.15885604 |
| 69 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.15258068 |
| 70 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.15209512 |
| 71 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.14935174 |
| 72 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.14744769 |
| 73 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.14354648 |
| 74 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.12998916 |
| 75 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.12909887 |
| 76 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.12677479 |
| 77 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.12329708 |
| 78 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.10905534 |
| 79 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.10308016 |
| 80 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.09913280 |
| 81 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.09286718 |
| 82 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.09286718 |
| 83 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.08067422 |
| 84 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.06497882 |
| 85 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.05634220 |
| 86 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05288927 |
| 87 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.04910180 |
| 88 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.04547987 |
| 89 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.03878106 |
| 90 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.03540080 |
| 91 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.00707007 |
| 92 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.00560825 |
| 93 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.98358831 |
| 94 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.97563930 |
| 95 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.97467025 |
| 96 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.97310313 |
| 97 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.95170371 |
| 98 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.94604647 |
| 99 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.93541391 |
| 100 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.92435036 |
| 101 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.91559983 |
| 102 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.91379830 |
| 103 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.91214390 |
| 104 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.90786357 |
| 105 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.90738667 |
| 106 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.89974264 |
| 107 | SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.89517961 |
| 108 | * ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.89483962 |
| 109 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88377595 |
| 110 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.86642024 |
| 111 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.86587918 |
| 112 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.86548590 |
| 113 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.86281462 |
| 114 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86038208 |
| 115 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.86033453 |
| 116 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.85487193 |
| 117 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.84720538 |
| 118 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.84247141 |
| 119 | P68_20966046_ChIP-Seq_HELA_Human | 0.83907430 |
| 120 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.82914463 |
| 121 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.82481106 |
| 122 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.82429008 |
| 123 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.82128726 |
| 124 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.81737913 |
| 125 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.81489148 |
| 126 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.81084936 |
| 127 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.81076230 |
| 128 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.80729208 |
| 129 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.80331898 |
| 130 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.80223187 |
| 131 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.80104924 |
| 132 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.78934643 |
| 133 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.78663164 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010368_abnormal_lymphatic_system | 5.11493276 |
| 2 | MP0004272_abnormal_basement_membrane | 4.16702802 |
| 3 | MP0008995_early_reproductive_senescence | 4.05051348 |
| 4 | MP0001879_abnormal_lymphatic_vessel | 3.34718873 |
| 5 | MP0005167_abnormal_blood-brain_barrier | 3.02198017 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 2.47449347 |
| 7 | MP0005670_abnormal_white_adipose | 2.40970140 |
| 8 | MP0001958_emphysema | 2.35402996 |
| 9 | MP0009115_abnormal_fat_cell | 2.35071865 |
| 10 | MP0001661_extended_life_span | 2.27013898 |
| 11 | MP0005377_hearing/vestibular/ear_phenot | 2.11318498 |
| 12 | MP0003878_abnormal_ear_physiology | 2.11318498 |
| 13 | MP0008438_abnormal_cutaneous_collagen | 2.06310983 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.03276600 |
| 15 | MP0002139_abnormal_hepatobiliary_system | 1.97380104 |
| 16 | MP0005623_abnormal_meninges_morphology | 1.88352637 |
| 17 | MP0000751_myopathy | 1.84689446 |
| 18 | MP0003195_calcinosis | 1.84272843 |
| 19 | MP0003959_abnormal_lean_body | 1.83113276 |
| 20 | MP0002970_abnormal_white_adipose | 1.82859071 |
| 21 | * MP0004084_abnormal_cardiac_muscle | 1.80734367 |
| 22 | MP0005334_abnormal_fat_pad | 1.80494110 |
| 23 | MP0004185_abnormal_adipocyte_glucose | 1.77586810 |
| 24 | MP0005666_abnormal_adipose_tissue | 1.74539663 |
| 25 | MP0004130_abnormal_muscle_cell | 1.72194397 |
| 26 | MP0003566_abnormal_cell_adhesion | 1.69615021 |
| 27 | MP0004782_abnormal_surfactant_physiolog | 1.67477454 |
| 28 | MP0005360_urolithiasis | 1.61887688 |
| 29 | MP0000639_abnormal_adrenal_gland | 1.60690231 |
| 30 | MP0010329_abnormal_lipoprotein_level | 1.54431906 |
| 31 | MP0000537_abnormal_urethra_morphology | 1.50210551 |
| 32 | MP0003828_pulmonary_edema | 1.49927652 |
| 33 | MP0003045_fibrosis | 1.47143215 |
| 34 | MP0009278_abnormal_bone_marrow | 1.43190860 |
| 35 | MP0002138_abnormal_hepatobiliary_system | 1.43175861 |
| 36 | MP0001756_abnormal_urination | 1.37602532 |
| 37 | MP0005375_adipose_tissue_phenotype | 1.36320034 |
| 38 | MP0000749_muscle_degeneration | 1.36064904 |
| 39 | MP0002108_abnormal_muscle_morphology | 1.35391770 |
| 40 | * MP0006138_congestive_heart_failure | 1.32569194 |
| 41 | MP0009643_abnormal_urine_homeostasis | 1.30231268 |
| 42 | MP0000759_abnormal_skeletal_muscle | 1.29063860 |
| 43 | MP0003300_gastrointestinal_ulcer | 1.29041791 |
| 44 | * MP0004036_abnormal_muscle_relaxation | 1.28690590 |
| 45 | MP0000013_abnormal_adipose_tissue | 1.28606772 |
| 46 | MP0005365_abnormal_bile_salt | 1.27933550 |
| 47 | MP0005058_abnormal_lysosome_morphology | 1.27801182 |
| 48 | MP0005535_abnormal_body_temperature | 1.21900625 |
| 49 | MP0000767_abnormal_smooth_muscle | 1.21078709 |
| 50 | MP0005275_abnormal_skin_tensile | 1.21039409 |
| 51 | MP0002168_other_aberrant_phenotype | 1.20971366 |
| 52 | MP0005332_abnormal_amino_acid | 1.20712227 |
| 53 | * MP0005595_abnormal_vascular_smooth | 1.20567806 |
| 54 | MP0002877_abnormal_melanocyte_morpholog | 1.18349977 |
| 55 | MP0002128_abnormal_blood_circulation | 1.18175803 |
| 56 | MP0008875_abnormal_xenobiotic_pharmacok | 1.17624694 |
| 57 | MP0008004_abnormal_stomach_pH | 1.15714196 |
| 58 | MP0005409_darkened_coat_color | 1.15585066 |
| 59 | MP0003115_abnormal_respiratory_system | 1.14941359 |
| 60 | MP0005330_cardiomyopathy | 1.13256698 |
| 61 | MP0001727_abnormal_embryo_implantation | 1.12798798 |
| 62 | MP0002876_abnormal_thyroid_physiology | 1.12400426 |
| 63 | MP0005165_increased_susceptibility_to | 1.11673127 |
| 64 | * MP0010630_abnormal_cardiac_muscle | 1.11550584 |
| 65 | MP0000003_abnormal_adipose_tissue | 1.11099388 |
| 66 | MP0008961_abnormal_basal_metabolism | 1.11007797 |
| 67 | MP0003724_increased_susceptibility_to | 1.10677374 |
| 68 | MP0003868_abnormal_feces_composition | 1.10080476 |
| 69 | MP0003186_abnormal_redox_activity | 1.09892737 |
| 70 | * MP0001544_abnormal_cardiovascular_syste | 1.09550000 |
| 71 | * MP0005385_cardiovascular_system_phenoty | 1.09550000 |
| 72 | MP0008877_abnormal_DNA_methylation | 1.05609983 |
| 73 | * MP0000343_altered_response_to | 1.04156153 |
| 74 | MP0008775_abnormal_heart_ventricle | 1.03884740 |
| 75 | MP0001849_ear_inflammation | 1.03269162 |
| 76 | MP0003091_abnormal_cell_migration | 1.02129726 |
| 77 | MP0002933_joint_inflammation | 1.01725153 |
| 78 | MP0003786_premature_aging | 1.01360246 |
| 79 | MP0009384_cardiac_valve_regurgitation | 1.01153330 |
| 80 | MP0005085_abnormal_gallbladder_physiolo | 1.00712573 |
| 81 | * MP0004087_abnormal_muscle_fiber | 1.00601430 |
| 82 | MP0003279_aneurysm | 1.00074504 |
| 83 | MP0003252_abnormal_bile_duct | 0.98360621 |
| 84 | MP0000609_abnormal_liver_physiology | 0.98186046 |
| 85 | MP0002118_abnormal_lipid_homeostasis | 0.97675431 |
| 86 | * MP0005319_abnormal_enzyme/_coenzyme | 0.96754149 |
| 87 | MP0000747_muscle_weakness | 0.95941071 |
| 88 | MP0005448_abnormal_energy_balance | 0.95841304 |
| 89 | * MP0000230_abnormal_systemic_arterial | 0.94511175 |
| 90 | MP0002837_dystrophic_cardiac_calcinosis | 0.94414384 |
| 91 | MP0002925_abnormal_cardiovascular_devel | 0.93726565 |
| 92 | MP0005076_abnormal_cell_differentiation | 0.93650164 |
| 93 | MP0003950_abnormal_plasma_membrane | 0.93374027 |
| 94 | * MP0001614_abnormal_blood_vessel | 0.91486829 |
| 95 | MP0000750_abnormal_muscle_regeneration | 0.90699283 |
| 96 | * MP0005647_abnormal_sex_gland | 0.90571100 |
| 97 | MP0002136_abnormal_kidney_physiology | 0.89699187 |
| 98 | MP0004215_abnormal_myocardial_fiber | 0.89132789 |
| 99 | MP0003948_abnormal_gas_homeostasis | 0.87461046 |
| 100 | MP0005452_abnormal_adipose_tissue | 0.87323960 |
| 101 | MP0003690_abnormal_glial_cell | 0.86615062 |
| 102 | MP0010030_abnormal_orbit_morphology | 0.85222478 |
| 103 | MP0000249_abnormal_blood_vessel | 0.84142681 |
| 104 | MP0003119_abnormal_digestive_system | 0.84116585 |
| 105 | MP0003011_delayed_dark_adaptation | 0.83415618 |
| 106 | MP0001915_intracranial_hemorrhage | 0.83033874 |
| 107 | * MP0000266_abnormal_heart_morphology | 0.81745013 |
| 108 | MP0003075_altered_response_to | 0.80829329 |
| 109 | MP0009780_abnormal_chondrocyte_physiolo | 0.80647528 |
| 110 | MP0003567_abnormal_fetal_cardiomyocyte | 0.80483198 |
| 111 | MP0002135_abnormal_kidney_morphology | 0.80130929 |
| 112 | MP0003942_abnormal_urinary_system | 0.79556264 |
| 113 | MP0002127_abnormal_cardiovascular_syste | 0.79503637 |
| 114 | MP0003283_abnormal_digestive_organ | 0.78033101 |
| 115 | MP0002971_abnormal_brown_adipose | 0.78017581 |
| 116 | MP0002909_abnormal_adrenal_gland | 0.77312469 |
| 117 | * MP0002295_abnormal_pulmonary_circulatio | 0.77283481 |
| 118 | MP0000534_abnormal_ureter_morphology | 0.76485301 |
| 119 | MP0005369_muscle_phenotype | 0.76022650 |
| 120 | MP0009840_abnormal_foam_cell | 0.75355182 |
| 121 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.75318694 |
| 122 | MP0004233_abnormal_muscle_weight | 0.75280152 |
| 123 | MP0002060_abnormal_skin_morphology | 0.74474832 |
| 124 | MP0002254_reproductive_system_inflammat | 0.74235075 |
| 125 | MP0006054_spinal_hemorrhage | 0.73871571 |
| 126 | MP0000733_abnormal_muscle_development | 0.73461265 |
| 127 | MP0005620_abnormal_muscle_contractility | 0.73116810 |
| 128 | MP0002269_muscular_atrophy | 0.72921934 |
| 129 | MP0004484_altered_response_of | 0.72445923 |
| 130 | MP0002972_abnormal_cardiac_muscle | 0.72365118 |
| 131 | MP0002133_abnormal_respiratory_system | 0.71394394 |
| 132 | MP0005388_respiratory_system_phenotype | 0.71394394 |
| 133 | MP0002078_abnormal_glucose_homeostasis | 0.71318501 |
| 134 | MP0005503_abnormal_tendon_morphology | 0.71164217 |
| 135 | MP0004883_abnormal_blood_vessel | 0.70901599 |
| 136 | MP0002332_abnormal_exercise_endurance | 0.69491053 |
| 137 | MP0002086_abnormal_extraembryonic_tissu | 0.69468846 |
| 138 | MP0002106_abnormal_muscle_physiology | 0.69392160 |
| 139 | MP0002796_impaired_skin_barrier | 0.67871389 |
| 140 | MP0005164_abnormal_response_to | 0.65914233 |
| 141 | MP0005023_abnormal_wound_healing | 0.64405772 |
| 142 | MP0003303_peritoneal_inflammation | 0.63705163 |
| 143 | MP0006036_abnormal_mitochondrial_physio | 0.63204086 |
| 144 | MP0005451_abnormal_body_composition | 0.63069310 |
| 145 | MP0002998_abnormal_bone_remodeling | 0.61575388 |
| 146 | MP0005508_abnormal_skeleton_morphology | 0.60890301 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Mesangial abnormality (HP:0001966) | 5.69184770 |
| 2 | Gonadal dysgenesis (HP:0000133) | 5.24143698 |
| 3 | Oligomenorrhea (HP:0000876) | 4.75043658 |
| 4 | Male infertility (HP:0003251) | 4.47178957 |
| 5 | Polycythemia (HP:0001901) | 4.39520455 |
| 6 | Lymphangioma (HP:0100764) | 4.10022268 |
| 7 | Hypertriglyceridemia (HP:0002155) | 4.03128512 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 4.02961933 |
| 9 | Renal salt wasting (HP:0000127) | 4.01493474 |
| 10 | Cerebral aneurysm (HP:0004944) | 3.84412898 |
| 11 | Focal segmental glomerulosclerosis (HP:0000097) | 3.84241740 |
| 12 | Testicular neoplasm (HP:0010788) | 3.81861881 |
| 13 | Deep venous thrombosis (HP:0002625) | 3.53653630 |
| 14 | Hematochezia (HP:0002573) | 3.49855685 |
| 15 | Rectal prolapse (HP:0002035) | 3.44996721 |
| 16 | Ankle contracture (HP:0006466) | 3.39482365 |
| 17 | Hypercholesterolemia (HP:0003124) | 3.36892305 |
| 18 | Myocardial infarction (HP:0001658) | 3.33245681 |
| 19 | Abnormality of complement system (HP:0005339) | 3.33079485 |
| 20 | Gonadotropin excess (HP:0000837) | 3.31227938 |
| 21 | Glomerulosclerosis (HP:0000096) | 3.27392903 |
| 22 | Metaphyseal cupping (HP:0003021) | 3.27145878 |
| 23 | Sex reversal (HP:0012245) | 3.20368163 |
| 24 | Abnormal sex determination (HP:0012244) | 3.20368163 |
| 25 | Nephritis (HP:0000123) | 3.17856554 |
| 26 | Facial diplegia (HP:0001349) | 3.14785004 |
| 27 | Increased connective tissue (HP:0009025) | 3.09167599 |
| 28 | Premature rupture of membranes (HP:0001788) | 2.97145061 |
| 29 | Vertebral compression fractures (HP:0002953) | 2.94017291 |
| 30 | Broad metatarsal (HP:0001783) | 2.92613221 |
| 31 | Hyporeflexia of lower limbs (HP:0002600) | 2.92455455 |
| 32 | Hand muscle atrophy (HP:0009130) | 2.90645289 |
| 33 | Esophageal varix (HP:0002040) | 2.89483860 |
| 34 | Visceral angiomatosis (HP:0100761) | 2.84699694 |
| 35 | Azoospermia (HP:0000027) | 2.84048845 |
| 36 | Abnormality of the nasal mucosa (HP:0000433) | 2.78724949 |
| 37 | Insulin resistance (HP:0000855) | 2.77606712 |
| 38 | Asymmetric septal hypertrophy (HP:0001670) | 2.77257859 |
| 39 | Distal lower limb muscle weakness (HP:0009053) | 2.73097363 |
| 40 | Axonal loss (HP:0003447) | 2.71760377 |
| 41 | Aneurysm (HP:0002617) | 2.70659893 |
| 42 | Protrusio acetabuli (HP:0003179) | 2.66291306 |
| 43 | Abnormality of the periventricular white matter (HP:0002518) | 2.64810986 |
| 44 | Hemangiomatosis (HP:0007461) | 2.63959615 |
| 45 | Distal lower limb amyotrophy (HP:0008944) | 2.63704839 |
| 46 | Spontaneous hematomas (HP:0007420) | 2.62377177 |
| 47 | Male pseudohermaphroditism (HP:0000037) | 2.61799890 |
| 48 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.59767709 |
| 49 | Osteolytic defects of the hand bones (HP:0009699) | 2.59767709 |
| 50 | Difficulty running (HP:0009046) | 2.59111145 |
| 51 | Hyperkalemia (HP:0002153) | 2.55935185 |
| 52 | Muscle fiber splitting (HP:0003555) | 2.55620007 |
| 53 | Bulbar palsy (HP:0001283) | 2.54004107 |
| 54 | Aortic aneurysm (HP:0004942) | 2.49286825 |
| 55 | Upper limb amyotrophy (HP:0009129) | 2.49236365 |
| 56 | Distal upper limb amyotrophy (HP:0007149) | 2.49236365 |
| 57 | Neck muscle weakness (HP:0000467) | 2.48968935 |
| 58 | Stage 5 chronic kidney disease (HP:0003774) | 2.47666563 |
| 59 | Ectopia lentis (HP:0001083) | 2.46131212 |
| 60 | Muscle fibrillation (HP:0010546) | 2.46105664 |
| 61 | Colitis (HP:0002583) | 2.42828737 |
| 62 | Vacuolated lymphocytes (HP:0001922) | 2.41997698 |
| 63 | Germ cell neoplasia (HP:0100728) | 2.41558746 |
| 64 | Lipoatrophy (HP:0100578) | 2.40842775 |
| 65 | Interstitial pulmonary disease (HP:0006530) | 2.40353592 |
| 66 | Enlarged penis (HP:0000040) | 2.39990345 |
| 67 | Hyperglycinuria (HP:0003108) | 2.39955398 |
| 68 | Myotonia (HP:0002486) | 2.31317054 |
| 69 | Wormian bones (HP:0002645) | 2.30368882 |
| 70 | Increased variability in muscle fiber diameter (HP:0003557) | 2.30135073 |
| 71 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.26890548 |
| 72 | Hemorrhage of the eye (HP:0011885) | 2.26584410 |
| 73 | Hypercortisolism (HP:0001578) | 2.26098167 |
| 74 | Type 1 muscle fiber predominance (HP:0003803) | 2.24097540 |
| 75 | Stridor (HP:0010307) | 2.23303398 |
| 76 | Rhabdomyolysis (HP:0003201) | 2.22280230 |
| 77 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.21512809 |
| 78 | Skin nodule (HP:0200036) | 2.21266706 |
| 79 | Abnormality of renin-angiotensin system (HP:0000847) | 2.19203032 |
| 80 | Mitral valve prolapse (HP:0001634) | 2.18956125 |
| 81 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.18555466 |
| 82 | Nausea (HP:0002018) | 2.17498742 |
| 83 | Wrist flexion contracture (HP:0001239) | 2.14865425 |
| 84 | Growth hormone excess (HP:0000845) | 2.13777853 |
| 85 | Dilatation of the ascending aorta (HP:0005111) | 2.13079623 |
| 86 | Polygenic inheritance (HP:0010982) | 2.12680826 |
| 87 | Abnormal albumin level (HP:0012116) | 2.09707269 |
| 88 | Hypoalbuminemia (HP:0003073) | 2.09707269 |
| 89 | Conjunctival telangiectasia (HP:0000524) | 2.09037260 |
| 90 | Complement deficiency (HP:0004431) | 2.08725107 |
| 91 | Increased circulating renin level (HP:0000848) | 2.08153355 |
| 92 | Hyperaldosteronism (HP:0000859) | 2.07466662 |
| 93 | Cerebral hemorrhage (HP:0001342) | 2.07171678 |
| 94 | Hyperlipoproteinemia (HP:0010980) | 2.04386498 |
| 95 | Striae distensae (HP:0001065) | 2.03853707 |
| 96 | Abnormality of the lower motor neuron (HP:0002366) | 2.03584658 |
| 97 | Foot dorsiflexor weakness (HP:0009027) | 2.01020643 |
| 98 | Exercise-induced myalgia (HP:0003738) | 2.00709927 |
| 99 | Amyloidosis (HP:0011034) | 2.00613435 |
| 100 | Bladder diverticulum (HP:0000015) | 2.00386218 |
| 101 | Atrioventricular block (HP:0001678) | 2.00187940 |
| 102 | Pulmonary hypertension (HP:0002092) | 1.99403328 |
| 103 | Nuclear cataract (HP:0100018) | 1.98980717 |
| 104 | Hypoplasia of the uterus (HP:0000013) | 1.97730157 |
| 105 | Difficulty climbing stairs (HP:0003551) | 1.96755784 |
| 106 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.96439144 |
| 107 | Joint hemorrhage (HP:0005261) | 1.96126313 |
| 108 | Hypoglycemic coma (HP:0001325) | 1.95684827 |
| 109 | Shawl scrotum (HP:0000049) | 1.95540090 |
| 110 | Round ear (HP:0100830) | 1.95352567 |
| 111 | Diaphragmatic weakness (HP:0009113) | 1.93605139 |
| 112 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.93549826 |
| 113 | Cervical subluxation (HP:0003308) | 1.93171183 |
| 114 | Bone cyst (HP:0012062) | 1.93014187 |
| 115 | Skull defect (HP:0001362) | 1.92815886 |
| 116 | Vascular tortuosity (HP:0004948) | 1.92257590 |
| 117 | Persistence of primary teeth (HP:0006335) | 1.91745283 |
| 118 | Sudden death (HP:0001699) | 1.91528285 |
| 119 | Tubulointerstitial fibrosis (HP:0005576) | 1.91020910 |
| 120 | Pulmonary artery stenosis (HP:0004415) | 1.90068933 |
| 121 | Scapular winging (HP:0003691) | 1.90057987 |
| 122 | Myoglobinuria (HP:0002913) | 1.90043142 |
| 123 | EMG: myopathic abnormalities (HP:0003458) | 1.89541172 |
| 124 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.88996938 |
| 125 | Acanthosis nigricans (HP:0000956) | 1.88951552 |
| 126 | Steatorrhea (HP:0002570) | 1.88056815 |
| 127 | Aortic dissection (HP:0002647) | 1.87664699 |
| 128 | Hyperpituitarism (HP:0010514) | 1.87551142 |
| 129 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.86774191 |
| 130 | Abnormal spermatogenesis (HP:0008669) | 1.86259352 |
| 131 | Hypoplastic left heart (HP:0004383) | 1.85572362 |
| 132 | Joint stiffness (HP:0001387) | 1.85380565 |
| 133 | Stroke (HP:0001297) | 1.85316075 |
| 134 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.85302583 |
| 135 | Abnormality of glycine metabolism (HP:0010895) | 1.85302583 |
| 136 | Hypoplasia of the iris (HP:0007676) | 1.85229815 |
| 137 | Right ventricular cardiomyopathy (HP:0011663) | 1.85080237 |
| 138 | Impaired pain sensation (HP:0007328) | 1.84366397 |
| 139 | Abnormality of pain sensation (HP:0010832) | 1.84366397 |
| 140 | Back pain (HP:0003418) | 1.84302456 |
| 141 | Hydroxyprolinuria (HP:0003080) | 1.84112532 |
| 142 | Abnormality of proline metabolism (HP:0010907) | 1.84112532 |
| 143 | Spinal rigidity (HP:0003306) | 1.83696058 |
| 144 | Glomerulonephritis (HP:0000099) | 1.83271382 |
| 145 | Abnormality of the foot musculature (HP:0001436) | 1.82282011 |
| 146 | Pigmentary retinal degeneration (HP:0001146) | 1.82009188 |
| 147 | Gout (HP:0001997) | 1.80376171 |
| 148 | Hyperactive renin-angiotensin system (HP:0000841) | 1.78167784 |
| 149 | Hyperammonemia (HP:0001987) | 1.78020378 |
| 150 | Lower limb amyotrophy (HP:0007210) | 1.77722707 |
| 151 | Venous abnormality (HP:0002624) | 1.77421326 |
| 152 | Nonimmune hydrops fetalis (HP:0001790) | 1.77375384 |
| 153 | Cavernous hemangioma (HP:0001048) | 1.77003984 |
| 154 | Hematuria (HP:0000790) | 1.76571269 |
| 155 | Bronchomalacia (HP:0002780) | 1.76519286 |
| 156 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.73618896 |
| 157 | Neonatal onset (HP:0003623) | 1.73410160 |
| 158 | Increased muscle lipid content (HP:0009058) | 1.73180789 |
| 159 | Adactyly (HP:0009776) | 1.72845364 |
| 160 | Tongue fasciculations (HP:0001308) | 1.72650996 |
| 161 | Shallow orbits (HP:0000586) | 1.71428302 |
| 162 | Secondary amenorrhea (HP:0000869) | 1.71145035 |
| 163 | Ventricular tachycardia (HP:0004756) | 1.71116725 |
| 164 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.71061422 |
| 165 | Hypoalphalipoproteinemia (HP:0003233) | 1.70850588 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 6.50358101 |
| 2 | TRIB3 | 4.24004506 |
| 3 | KDR | 3.45517603 |
| 4 | RIPK1 | 3.04808816 |
| 5 | ERN1 | 2.76598075 |
| 6 | TGFBR2 | 2.73827262 |
| 7 | CDK12 | 2.39098178 |
| 8 | TYRO3 | 2.24724403 |
| 9 | MYLK | 2.16933467 |
| 10 | EPHB2 | 2.15590107 |
| 11 | PTK6 | 2.07752502 |
| 12 | PAK4 | 2.02892129 |
| 13 | WNK4 | 1.96025861 |
| 14 | PKN2 | 1.95902718 |
| 15 | PDGFRA | 1.91554814 |
| 16 | LATS1 | 1.91304580 |
| 17 | EPHB1 | 1.89613848 |
| 18 | ICK | 1.86026507 |
| 19 | BCKDK | 1.80880438 |
| 20 | MAP3K6 | 1.72284259 |
| 21 | TTN | 1.67872653 |
| 22 | FGFR4 | 1.66233311 |
| 23 | SIK1 | 1.60945371 |
| 24 | PDK3 | 1.55762990 |
| 25 | PDK4 | 1.55762990 |
| 26 | TGFBR1 | 1.54959101 |
| 27 | CAMK1D | 1.52124859 |
| 28 | PRKD3 | 1.51312145 |
| 29 | PTK2B | 1.44237068 |
| 30 | PRPF4B | 1.33950502 |
| 31 | MAP3K13 | 1.32976709 |
| 32 | TRPM7 | 1.32513170 |
| 33 | FER | 1.32312088 |
| 34 | TESK1 | 1.28607645 |
| 35 | PDK2 | 1.25737180 |
| 36 | AKT3 | 1.22567679 |
| 37 | MAPK4 | 1.17370958 |
| 38 | CAMK1G | 1.14452828 |
| 39 | EPHA3 | 1.12518961 |
| 40 | LMTK2 | 1.11875934 |
| 41 | WNK3 | 1.10846531 |
| 42 | FES | 1.10604742 |
| 43 | FGFR2 | 1.06049960 |
| 44 | CAMK1 | 1.04670028 |
| 45 | RPS6KA2 | 1.03860258 |
| 46 | MTOR | 1.03606119 |
| 47 | PTK2 | 1.00609618 |
| 48 | MST1R | 1.00136890 |
| 49 | OBSCN | 0.96439786 |
| 50 | ABL2 | 0.95922644 |
| 51 | ARAF | 0.95626417 |
| 52 | LRRK2 | 0.93521188 |
| 53 | MAP2K3 | 0.92810683 |
| 54 | MET | 0.92185884 |
| 55 | DMPK | 0.91661623 |
| 56 | CDK7 | 0.90632112 |
| 57 | LATS2 | 0.88671799 |
| 58 | MAPK7 | 0.84828415 |
| 59 | MOS | 0.81937296 |
| 60 | GSK3A | 0.78273307 |
| 61 | MAP3K3 | 0.77321341 |
| 62 | STK3 | 0.76335932 |
| 63 | STK38L | 0.75056909 |
| 64 | BMX | 0.73711836 |
| 65 | SMG1 | 0.73553159 |
| 66 | PAK2 | 0.72755564 |
| 67 | MAP3K10 | 0.72234710 |
| 68 | NLK | 0.71639054 |
| 69 | PDGFRB | 0.70659360 |
| 70 | DAPK2 | 0.69759412 |
| 71 | PRKD1 | 0.67489357 |
| 72 | MAPKAPK5 | 0.67104997 |
| 73 | MARK2 | 0.65888299 |
| 74 | WNK1 | 0.65768557 |
| 75 | CDK9 | 0.64720152 |
| 76 | EPHA2 | 0.62926360 |
| 77 | CSK | 0.62455191 |
| 78 | MAP2K2 | 0.62453840 |
| 79 | PRKAA2 | 0.60873429 |
| 80 | MAPK15 | 0.59787375 |
| 81 | FGFR1 | 0.58416643 |
| 82 | FGFR3 | 0.58290786 |
| 83 | GRK1 | 0.57276260 |
| 84 | CDK4 | 0.57070703 |
| 85 | JAK3 | 0.56963244 |
| 86 | AKT2 | 0.56795198 |
| 87 | STK39 | 0.56245250 |
| 88 | DAPK3 | 0.55791271 |
| 89 | BRD4 | 0.54767555 |
| 90 | STK24 | 0.51970911 |
| 91 | PHKG2 | 0.51653858 |
| 92 | PHKG1 | 0.51653858 |
| 93 | RPS6KC1 | 0.51326907 |
| 94 | RPS6KL1 | 0.51326907 |
| 95 | MAP3K7 | 0.51066754 |
| 96 | ILK | 0.51024522 |
| 97 | CDK6 | 0.49773852 |
| 98 | RET | 0.49078560 |
| 99 | MAPKAPK3 | 0.46463281 |
| 100 | GRK5 | 0.44393025 |
| 101 | BLK | 0.43948905 |
| 102 | DDR2 | 0.43866226 |
| 103 | PRKD2 | 0.43497026 |
| 104 | ROCK1 | 0.43137642 |
| 105 | EGFR | 0.42320567 |
| 106 | PRKCH | 0.40211119 |
| 107 | PDPK1 | 0.40117679 |
| 108 | RPS6KB2 | 0.40076177 |
| 109 | CDC42BPA | 0.39583369 |
| 110 | NEK1 | 0.39041295 |
| 111 | TYK2 | 0.37782874 |
| 112 | SGK494 | 0.37145300 |
| 113 | SGK223 | 0.37145300 |
| 114 | FLT3 | 0.36828360 |
| 115 | MAP2K1 | 0.36404472 |
| 116 | PRKAA1 | 0.35759684 |
| 117 | MAPK3 | 0.35652146 |
| 118 | PDK1 | 0.35604784 |
| 119 | * PRKACG | 0.35502511 |
| 120 | NME2 | 0.35382399 |
| 121 | NEK9 | 0.33411830 |
| 122 | MAPK12 | 0.33348131 |
| 123 | MAP3K11 | 0.32750525 |
| 124 | JAK2 | 0.32391245 |
| 125 | RPS6KA6 | 0.32179638 |
| 126 | PRKG2 | 0.32098568 |
| 127 | EEF2K | 0.31771275 |
| 128 | CHUK | 0.31430164 |
| 129 | YES1 | 0.31022253 |
| 130 | SGK2 | 0.30248063 |
| 131 | PAK1 | 0.29984941 |
| 132 | PRKG1 | 0.29056611 |
| 133 | NEK2 | 0.28964468 |
| 134 | IGF1R | 0.28565340 |
| 135 | PAK3 | 0.27942705 |
| 136 | STK10 | 0.27600487 |
| 137 | JAK1 | 0.27438326 |
| 138 | SGK3 | 0.27359564 |
| 139 | ZAP70 | 0.26568378 |
| 140 | MAP3K1 | 0.26555145 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid metabolism_Homo sapiens_hsa01212 | 3.17911447 |
| 2 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.11382270 |
| 3 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.85748381 |
| 4 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.69306894 |
| 5 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.65180955 |
| 6 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.59879681 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.53467560 |
| 8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.39253063 |
| 9 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.36323978 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.01677141 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.96660943 |
| 12 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.87638674 |
| 13 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.86344125 |
| 14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.82093696 |
| 15 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.76356022 |
| 16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.75748697 |
| 17 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.75243868 |
| 18 | Focal adhesion_Homo sapiens_hsa04510 | 1.73460846 |
| 19 | Lysine degradation_Homo sapiens_hsa00310 | 1.69149988 |
| 20 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.64919428 |
| 21 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.64067333 |
| 22 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.56522214 |
| 23 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.55349924 |
| 24 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.52270148 |
| 25 | Amoebiasis_Homo sapiens_hsa05146 | 1.52115591 |
| 26 | Bile secretion_Homo sapiens_hsa04976 | 1.49290200 |
| 27 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.47749014 |
| 28 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.47407085 |
| 29 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.45992951 |
| 30 | Other glycan degradation_Homo sapiens_hsa00511 | 1.38841103 |
| 31 | Carbon metabolism_Homo sapiens_hsa01200 | 1.35535546 |
| 32 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.32894000 |
| 33 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.30816722 |
| 34 | Insulin resistance_Homo sapiens_hsa04931 | 1.30646836 |
| 35 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.27848851 |
| 36 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.26195003 |
| 37 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.21088236 |
| 38 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.15965175 |
| 39 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.15157870 |
| 40 | Adherens junction_Homo sapiens_hsa04520 | 1.13503615 |
| 41 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.10814709 |
| 42 | * Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.09142687 |
| 43 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.05529436 |
| 44 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.05410562 |
| 45 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.98394274 |
| 46 | Sulfur relay system_Homo sapiens_hsa04122 | 0.96777149 |
| 47 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.96239522 |
| 48 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.95236108 |
| 49 | Tight junction_Homo sapiens_hsa04530 | 0.92560809 |
| 50 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.92504288 |
| 51 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.92079459 |
| 52 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.91702882 |
| 53 | * Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.88733864 |
| 54 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.87837877 |
| 55 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.86869196 |
| 56 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.84652978 |
| 57 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.84005705 |
| 58 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.82745556 |
| 59 | Malaria_Homo sapiens_hsa05144 | 0.81833419 |
| 60 | Peroxisome_Homo sapiens_hsa04146 | 0.80951411 |
| 61 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.79362064 |
| 62 | * Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.77404720 |
| 63 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.77035055 |
| 64 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.76636104 |
| 65 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.76622943 |
| 66 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.75095697 |
| 67 | Lysosome_Homo sapiens_hsa04142 | 0.74557487 |
| 68 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.72055482 |
| 69 | Viral myocarditis_Homo sapiens_hsa05416 | 0.71637407 |
| 70 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.71140774 |
| 71 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.71075832 |
| 72 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.68727991 |
| 73 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.68093431 |
| 74 | ABC transporters_Homo sapiens_hsa02010 | 0.67021691 |
| 75 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.66355664 |
| 76 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.64679941 |
| 77 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.63367350 |
| 78 | Galactose metabolism_Homo sapiens_hsa00052 | 0.60853906 |
| 79 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.60762607 |
| 80 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.60383709 |
| 81 | Pertussis_Homo sapiens_hsa05133 | 0.60127698 |
| 82 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.60110411 |
| 83 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.59456783 |
| 84 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.58862008 |
| 85 | * Renin secretion_Homo sapiens_hsa04924 | 0.58484904 |
| 86 | Retinol metabolism_Homo sapiens_hsa00830 | 0.58085441 |
| 87 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.57389894 |
| 88 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.57355556 |
| 89 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.56536760 |
| 90 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.56038235 |
| 91 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.55680674 |
| 92 | Prion diseases_Homo sapiens_hsa05020 | 0.55596986 |
| 93 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.52987922 |
| 94 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.52276652 |
| 95 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.51453224 |
| 96 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.50432596 |
| 97 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.49908894 |
| 98 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.49593301 |
| 99 | Axon guidance_Homo sapiens_hsa04360 | 0.49275480 |
| 100 | Mineral absorption_Homo sapiens_hsa04978 | 0.49211672 |
| 101 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.48313522 |
| 102 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.47889399 |
| 103 | Histidine metabolism_Homo sapiens_hsa00340 | 0.47707385 |
| 104 | Pathways in cancer_Homo sapiens_hsa05200 | 0.47411468 |
| 105 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.46197816 |
| 106 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.45803935 |
| 107 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44820185 |
| 108 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.44265221 |
| 109 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.44263454 |
| 110 | Thyroid cancer_Homo sapiens_hsa05216 | 0.43574741 |
| 111 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.43504731 |
| 112 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.43406470 |
| 113 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.43241798 |
| 114 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.42367581 |
| 115 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.41953799 |
| 116 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.38501321 |
| 117 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.36518596 |
| 118 | Phagosome_Homo sapiens_hsa04145 | 0.35404648 |
| 119 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.33447515 |
| 120 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.31236423 |
| 121 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.30616880 |
| 122 | Platelet activation_Homo sapiens_hsa04611 | 0.30277547 |
| 123 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.30163008 |
| 124 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.29756906 |
| 125 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.29578856 |
| 126 | Gap junction_Homo sapiens_hsa04540 | 0.26985084 |
| 127 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.26078421 |
| 128 | Circadian rhythm_Homo sapiens_hsa04710 | 0.25750687 |
| 129 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.25629433 |

